CVS Health Corporation Ratios | P/E, ROE & Valuation

On the Key Ratios page for CVS Health Corporation (CVS), the latest P/E of 25.4 frames valuation, while ROE 6.43% and ROIC 4.09% indicates profitability and capital efficiency. Together with the current ratio of 0.87 and debt-to-equity 0.96, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

CVS Historical Per Share Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Revenue per Share$325.30$296.12$278.42$245.78$221.46$205.28$197.37$186.38$181.16$165.47
Net Income per Share$3.84$3.66$6.49$3.29$6.07$5.48$5.10$-0.57$6.49$4.96
Operating Cash Flow per Share$11.58$7.23$10.45$12.33$13.85$12.12$9.88$8.49$7.85$9.45
Free Cash Flow per Share$9.21$5.02$8.09$10.25$11.94$10.26$7.99$6.54$5.97$7.38
Cash per Share$10.94$8.73$8.91$11.98$9.50$8.29$6.19$6.30$1.77$3.22
Book Value per Share$62.62$60.15$59.64$54.70$57.15$53.25$49.32$56.08$36.96$34.33
Tangible Book Value per Share$-23.69$-34.05$-34.14$-23.77$-24.84$-31.32$-37.43$-54.27$-14.10$-13.91
Interest Debt per Share$62.23$68.21$63.85$55.65$59.52$67.19$70.74$72.84$27.51$26.66
CAPEX per Share$2.37$2.21$2.36$2.08$1.91$1.86$1.89$1.95$1.88$2.07

CVS Historical Valuation Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Price to Earnings (P/E)25.3912.2512.1628.3617.0112.4514.57-115.1611.1715.92
Price to Book (P/B)1.560.751.331.711.811.291.511.171.962.3
Price to Sales (P/S)0.30.150.280.380.470.330.380.350.40.48
Enterprise Value to EBITDA14.19.569.4914.5811.569.7310.9720.438.418.93
EV to Sales0.460.350.480.560.690.620.70.710.540.61
EV to Operating Cash Flow12.7914.3712.8611.1311.110.514.0115.5412.410.73
EV to Free Cash Flow16.0820.6816.6113.3912.8712.4117.3220.1816.313.75
Enterprise Value$189.04B$130.85B$172.65B$180.05B$202.66B$166.59B$179.97B$137.77B$99.26B$108.83B

CVS Historical Profitability Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Return on Equity (ROE)6.43%6.11%10.91%6.03%10.66%10.35%10.39%-1.02%17.57%14.44%
Return on Invested Capital (ROIC)4.09%3.61%5.87%3.63%5.90%5.83%5.06%-1.10%11.04%9.12%
Return on Tangible Assets3.42%3.43%6.46%3.44%6.41%5.98%6.05%-0.73%15.38%12.45%
Earnings Yield3.95%8.16%8.22%3.53%5.88%8.03%6.86%-0.87%8.95%6.28%
Free Cash Flow Yield9.48%11.19%10.25%11.00%11.57%15.02%10.75%9.98%8.23%9.35%
Dividend Yield2.74%5.97%3.09%2.38%1.93%2.93%2.69%2.98%2.77%2.17%

CVS Historical Liquidity & Financial Strength

10 years
Metric (FY)TTM202420232022202120202019201820172016
Current Ratio0.870.810.860.950.880.910.941.031.021.18
Interest Coverage2.672.885.173.485.324.793.951.548.989.62
Income Quality2.421.991.63.742.292.211.94-14.871.211.91
Debt to Equity0.961.11.040.991.011.231.391.260.720.75
Debt to Assets30.07%32.75%31.79%30.99%32.62%36.86%40.01%37.38%28.38%29.15%
Net Debt to EBITDA4.855.433.914.683.84.515.0810.292.141.98

CVS Historical Efficiency Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Receivables Turnover10.310.2210.1611.8211.9612.3613.0911.0414.0214.6
Payables Turnover20.7620.2220.3618.0619.1319.7220.1318.2717.6318.72
Inventory Turnover20.2217.7516.8314.0413.5111.8812.069.9110.2210.08
Days Sales Outstanding35.4535.7135.9430.8730.5329.5327.8933.0726.0425.01
Days Payables Outstanding17.5818.0517.9220.2119.0818.5118.1319.9820.719.5
Days of Inventory on Hand18.0520.5621.692627.0130.7330.2636.8335.7336.23

CVS Historical Market Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Enterprise Value to EBITDA14.19.569.4914.5811.569.7310.9720.438.418.93
Market Cap$124.06B$56.52B$101.46B$122.27B$136.07B$89.40B$96.65B$68.40B$73.95B$84.67B
Enterprise Value$189.04B$130.85B$172.65B$180.05B$202.66B$166.59B$179.97B$137.77B$99.26B$108.83B
Dividend Yield2.74%5.97%3.09%2.38%1.93%2.93%2.69%2.98%2.77%2.17%
Payout Ratio69.63%73.10%37.54%67.43%32.81%36.55%39.24%-343.10%30.94%34.61%

Frequently Asked Questions

How does CVS Health Corporation’s P/E ratio compare with its history?

On this page, CVS's current P/E is 25.4, compared with a multi-year average around 16.6. A higher P/E versus its own history is a calculated premium versus that average—not a conclusion that the stock is expensive. Cross-check profitability (ROE/ROIC), liquidity (current ratio), and leverage (debt-to-equity) so the multiple is read with those published figures.

What is CVS Health Corporation market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $124.06B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does CVS Health Corporation’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with CVS Health Corporation's own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does CVS Health Corporation compare to its competitors in key financial ratios?

The fastest way to compare CVS Health Corporation with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see CVS Health Corporation outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do CVS Health Corporation's liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that CVS Health Corporation is financially strong. Current ratio is about 0.87, which is below 1.0 and can suggest tighter short-term liquidity. Interest coverage is about 2.67, implying a stronger ability to cover interest expenses. Debt-to-equity is about 0.96, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do CVS Health Corporation's financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If CVS Health Corporation is sustaining strong returns (for example ROE at 6.43% and ROIC at 4.09%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.